The Next Evolution in Exosome Therapy — Synthetic Precision, Biological Power
Biovance™ Synthesome™ represents a revolutionary leap in regenerative medicine — a synthetically engineered exosome platform that replicates the natural signaling power of mesenchymal stem cell–derived exosomes while overcoming their biological limitations.
Developed in Biovance’s Netherlands R&D Facility, Synthesome™ is designed using nano-lipid vesicle technologyintegrated with engineered signaling peptides, microRNA analogs, and growth factor mimetics to achieve precise cellular communication and regenerative activation — without the variability, contamination risks, or ethical issues of biological sources.
Precision-Engineered Regeneration – delivers targeted molecular cues to stimulate cell repair, angiogenesis, and anti-inflammatory responses.
100% Synthetic & Bioidentical – free from donor variability, pathogens, and immunogenicity risks.
No Biological or Ethical Restrictions – fully compliant with EU and global regulatory standards for synthetic biologics.
Superior Stability & Shelf-Life – retains full activity without cryostorage or degradation.
Clinically Safe & Scalable – GMP-synthesized with consistent particle size, purity, and function in every batch.
Customizable Therapeutic Payloads – tunable for neurology, dermatology, anti-aging, orthopedics, and immune modulation applications.
Scientific Excellence
Biovance™ Synthesome™ is engineered through nanolipid vesicle self-assembly and biomimetic programming, replicating the functional profile of MSC exosomes.
Each vesicle is pre-loaded with synthetic analogs of regenerative microRNAs (e.g., miR-21, miR-126, miR-146a) and peptide growth factor mimetics that enhance angiogenesis, anti-inflammation, and mitochondrial repair.
Unlike biological exosomes, Synthesome™ maintains absolute reproducibility and zero contamination risk — enabling clinical-grade reliability and regulatory transparency across multiple therapeutic domains.
Certifications: GMP, ISO 13485, EU Nanomedicine Compliance, Endotoxin-Free Certification
Why Choose Biovance™ Synthesome™
Biovance™ Synthesome™ defines the future of exosome therapy — uniting precision engineering with biological intelligence.
Unlike donor-derived exosomes, Synthesome™ offers absolute purity, stability, safety, and regulatory clarity, enabling clinical translation at scale.
By eliminating donor dependence, biological variability, and pathogen risks, Biovance™ leads the next generation of synthetic regenerative nanomedicine — redefining how cellular communication and repair are delivered.
Address : 327 Windmill Street, 1017 ZX Amsterdam, The Netherlands
Factory : Industrieweg 89, 2031 BT Haarlem, The Netherlands
BIOVANCE™ SYNTHESOME™ hair & skin
The Next Evolution in Exosome Therapy — Synthetic Precision, Biological Power
Biovance™ Synthesome™ represents a revolutionary leap in regenerative medicine — a synthetically engineered exosome platform that replicates the natural signaling power of mesenchymal stem cell–derived exosomes while overcoming their biological limitations.
Developed in Biovance’s Netherlands R&D Facility, Synthesome™ is designed using nano-lipid vesicle technologyintegrated with engineered signaling peptides, microRNA analogs, and growth factor mimetics to achieve precise cellular communication and regenerative activation — without the variability, contamination risks, or ethical issues of biological sources.
Description
Key Benefits
Scientific Excellence
Biovance™ Synthesome™ is engineered through nanolipid vesicle self-assembly and biomimetic programming, replicating the functional profile of MSC exosomes.
Each vesicle is pre-loaded with synthetic analogs of regenerative microRNAs (e.g., miR-21, miR-126, miR-146a) and peptide growth factor mimetics that enhance angiogenesis, anti-inflammation, and mitochondrial repair.
Unlike biological exosomes, Synthesome™ maintains absolute reproducibility and zero contamination risk — enabling clinical-grade reliability and regulatory transparency across multiple therapeutic domains.
Competitive Advantage Table
Product Specifications
Why Choose Biovance™ Synthesome™
Biovance™ Synthesome™ defines the future of exosome therapy — uniting precision engineering with biological intelligence.
Unlike donor-derived exosomes, Synthesome™ offers absolute purity, stability, safety, and regulatory clarity, enabling clinical translation at scale.
By eliminating donor dependence, biological variability, and pathogen risks, Biovance™ leads the next generation of synthetic regenerative nanomedicine — redefining how cellular communication and repair are delivered.